Community engagement to implement evidence-based practices in the HEALing communities study.

Communities that heal Community engagement Community-Based participatory research HEALing communities study Helping to end addiction long-term Opioid use disorder (OUD) Overdose

Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 12 2020
Historique:
received: 22 08 2020
revised: 13 09 2020
accepted: 15 09 2020
pubmed: 16 10 2020
medline: 10 4 2021
entrez: 15 10 2020
Statut: ppublish

Résumé

The implementation of evidence-based practices to reduce opioid overdose deaths within communities remains suboptimal. Community engagement can improve the uptake and sustainability of evidence-based practices. The HEALing Communities Study (HCS) aims to reduce opioid overdose deaths through the Communities That HEAL (CTH) intervention, a community-engaged, data-driven planning process that will be implemented in 67 communities across four states. An iterative process was used in the development of the community engagement component of the CTH. The resulting community engagement process uses phased planning steeped in the principles of community based participatory research. Phases include: 0) Preparation, 1) Getting Started, 2) Getting Organized, 3) Community Profiles and Data Dashboards, 4) Community Action Planning, 5) Implementation and Monitoring, and 6) Sustainability Planning. The CTH protocol provides a common structure across the four states for the community-engaged intervention and allows for tailored approaches that meet the unique needs or sociocultural context of each community. Challenges inherent to community engagement work emerged early in the process are discussed. HCS will show how community engagement can support the implementation of evidence-based practices for addressing the opioid crisis in highly impacted communities. Findings from this study have the potential to provide communities across the country with an evidence-based approach to address their local opioid crisis; advance community engaged research; and contribute to the implementation, sustainability, and adoption of evidence-based practices. ClinicalTrials.gov (NCT04111939).

Sections du résumé

BACKGROUND
The implementation of evidence-based practices to reduce opioid overdose deaths within communities remains suboptimal. Community engagement can improve the uptake and sustainability of evidence-based practices. The HEALing Communities Study (HCS) aims to reduce opioid overdose deaths through the Communities That HEAL (CTH) intervention, a community-engaged, data-driven planning process that will be implemented in 67 communities across four states.
METHODS
An iterative process was used in the development of the community engagement component of the CTH. The resulting community engagement process uses phased planning steeped in the principles of community based participatory research. Phases include: 0) Preparation, 1) Getting Started, 2) Getting Organized, 3) Community Profiles and Data Dashboards, 4) Community Action Planning, 5) Implementation and Monitoring, and 6) Sustainability Planning.
DISCUSSION
The CTH protocol provides a common structure across the four states for the community-engaged intervention and allows for tailored approaches that meet the unique needs or sociocultural context of each community. Challenges inherent to community engagement work emerged early in the process are discussed.
CONCLUSION
HCS will show how community engagement can support the implementation of evidence-based practices for addressing the opioid crisis in highly impacted communities. Findings from this study have the potential to provide communities across the country with an evidence-based approach to address their local opioid crisis; advance community engaged research; and contribute to the implementation, sustainability, and adoption of evidence-based practices.
TRIAL REGISTRATION
ClinicalTrials.gov (NCT04111939).

Identifiants

pubmed: 33059200
pii: S0376-8716(20)30491-9
doi: 10.1016/j.drugalcdep.2020.108326
pmc: PMC7537729
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04111939']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

108326

Subventions

Organisme : NIDA NIH HHS
ID : UM1 DA049394
Pays : United States
Organisme : NIDA NIH HHS
ID : UM1 DA049415
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR002602
Pays : United States
Organisme : NIDA NIH HHS
ID : UM1 DA049412
Pays : United States
Organisme : NIDA NIH HHS
ID : UM1 DA049417
Pays : United States
Organisme : NIDA NIH HHS
ID : UM1 DA049406
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Drug Alcohol Depend. 2020 Dec 1;217:108331
pubmed: 33070058
Am J Community Psychol. 2011 Sep;48(1-2):31-42
pubmed: 21240547
Drug Alcohol Depend. 2020 Dec 1;217:108335
pubmed: 33248391
Am J Public Health. 2018 May;108(5):659-665
pubmed: 29565666
Am J Manag Care. 2016 Aug;22(12 Suppl):s423-36
pubmed: 27567516
Clin Transl Sci. 2014 Jun;7(3):191-5
pubmed: 24841362
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297
pubmed: 32191688
Transl Behav Med. 2017 Sep;7(3):389-392
pubmed: 28884305
Annu Rev Public Health. 2018 Apr 1;39:55-76
pubmed: 29328872
Drug Alcohol Depend. 2020 Dec 1;217:108338
pubmed: 33152673
Am J Public Health. 2011 May;101(5):822-30
pubmed: 21421960
Pain Med. 2011 Jun;12 Suppl 2:S77-85
pubmed: 21668761
Prev Sci. 2016 Oct;17(7):830-40
pubmed: 27392783
Health Educ Behav. 2004 Dec;31(6):684-97
pubmed: 15539542
J Community Psychol. 2016 Jan;44(1):78-89
pubmed: 27397946
Am J Public Health. 2003 Aug;93(8):1261-7
pubmed: 12893608
N Engl J Med. 2015 Jun 11;372(24):2277-9
pubmed: 26061832
Am J Public Health. 2010 Apr 1;100 Suppl 1:S40-6
pubmed: 20147663
J Adolesc Health. 2012 Sep;51(3):259-64
pubmed: 22921136
Am J Community Psychol. 2001 Apr;29(2):165-72; discussion 205-11
pubmed: 11446274
Front Public Health. 2018 Jul 11;6:190
pubmed: 30050895
Health Policy Plan. 2017 Dec 1;32(10):1457-1465
pubmed: 29092039
J Ambul Care Manage. 2016 Jan-Mar;39(1):2-11
pubmed: 26650741
Prev Sci. 2017 Jul;18(5):610-621
pubmed: 28397156
Drug Alcohol Depend. 2020 Dec 1;217:108325
pubmed: 33091842
Annu Rev Public Health. 1998;19:173-202
pubmed: 9611617
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Am Psychol. 2003 Jun-Jul;58(6-7):441-8
pubmed: 12971190
Inj Prev. 2018 Feb;24(1):48-54
pubmed: 28835443

Auteurs

Linda Sprague Martinez (L)

Macro Department, School of Social Work, Boston University, 264 Baystate Road, Boston, MA 02215, United States. Electronic address: lsmarti@bu.edu.

Bruce D Rapkin (BD)

Department of Epidemiology & Population Health, Albert Einstein College of Medicine, 1225 Morris Park Avenue, Van Etten, Room 3A2E, Bronx, NY 10461, United States.

April Young (A)

Department of Epidemiology, University of Kentucky College of Public Health, 111 Washington Avenue Office 211C, Lexington, KY 40536, United States.

Bridget Freisthler (B)

Ohio State University College of Social Work, 1947 College Rd N, Columbus, OH 43210, United States.

LaShawn Glasgow (L)

RTI International, 3040 East Cornwallis Road, Research Triangle Park, NC 27709-2194, United States.

Tim Hunt (T)

Columbia University, School of Social Work, Center for Healing of Opioid and Other Substance Use Disorders (CHOSEN), 1255 Amsterdam, Avenue, Rm 806, New York, NY 10027, United States.

Pamela J Salsberry (PJ)

Ohio State University College of Public Health, 250 Cunz Hall, 1841 Neil Ave., Columbus, OH 43210, United States.

Emmanuel A Oga (EA)

RTI International, 3040 East Cornwallis Road, Research Triangle Park, NC 27709-2194, United States.

Amanda Bennet-Fallin (A)

University of Kentucky College of Nursing, 751 Rose Street, Lexington, KY 40536-0232, United States.

Tracy J Plouck (TJ)

College of Health Sciences and Professions, Ohio University, 1 Ohio University Drive, Athens, OH 45701, United States.

Mari-Lynn Drainoni (ML)

Section of Infectious Diseases, School of Medicine, & Department of Health Law Policy, School of Public Health, Boston University, 801 Massachusetts Avenue 2ndFloor, Boston, MA 02118, United States.

Patricia R Freeman (PR)

Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, 789 S Limestone St, Lexington, KY 40536, United States.

Hilary Surratt (H)

Department of Behavioral Science, College of Medicine, University of Kentucky, 125 Medical Behavioral Science Building, Lexington, KY 40536-0298, United States.

Jennifer Gulley (J)

Clark County Health Department, 400 Professional Ave, Winchester, KY 40391, United States.

Greer A Hamilton (GA)

School Work, Boston University, 264 Baystate Road, Boston, MA 02215, United States.

Paul Bowman (P)

South End Community Health Center, 1601 Washington St, Boston, MA 02118, United States.

Carter A Roeber (CA)

National Mental Health and Substance Use Policy Laboratory, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, United States.

Nabila El-Bassel (N)

Columbia University School of Social Work, 1255 Amsterdam Avenue, New York, NY 10027-5927, United States.

Tracy Battaglia (T)

Women's Health Unit Boston Medical Center, Schools of Medicine & Public Health, Boston University, 801 Massachusetts Avenue 2ndFloor, Boston, MA 02118, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH